Medeligo® — Oncology's Leading Search Tool
Created by physicians, medical librarians, and technologists, MEDELIGO® leverages AI to provide instant access to oncology information resources.
THE MEDELIGO® ENGINE
State-of-the-Art: AI-powered search engineered by technologists and librarians
Trusted: Searches only trusted medical journals, databases and resources
Robust: Covers more than 2,000 solid tumors and cancers
Time-saving: Effortless UI provides answers in seconds
Unbiased: Primary source material: unfiltered, unbiased, uncurated
Current: Real-time searches present the latest oncology information available. For example:
- What are the latest treatments for recurrent hepatocellular carcinoma?
- What are the latest immunotherapy advances for glioblastoma?
Unbiased: Primary source material: unfiltered, unbiased, uncurated
3-Month Free Trial
Only $24.99/year after trial
Scan to download the app
On your phone? Click here to go directly to the App Store
What are the latest immunotherapy advances for glioblastoma?
Medeligo® — Oncology's Leading Search Tool
Created by physicians, medical librarians, and technologists, Medeligo® leverages AI to provide instant access to oncology information resources.
State-of-the-Art: AI-powered search engineered by technologists and librarians
Trusted: Searches only trusted medical journals, databases and resources
Robust: Covers more than 2,000 solid tumors and cancers
Time-saving: Effortless UI provides answers in seconds
Current: Real-time searches present the latest oncology information available, for example:
- What are the latest treatments for recurrent hepatocellular carcinoma?
- What are the latest immunotherapy advances for glioblastoma?
Unbiased: Primary source material: unfiltered, unbiased, uncurated
